International Menopause Society Calls Upon Medical Community to Improve the Vaginal Health of Postmenopausal Women

New Treatment Recommendations Urge Women and Doctors to Overcome the Taboo of Postmenopausal Vaginal Atrophy

LONDON, October 7, 2010 – To mark World Menopause Day on 18th October 2010, the International
Menopause Society (IMS) is launching new Recommendations for the management
of postmenopausal vaginal atrophy, a distressing condition that will affect
up to half of women after menopause.[1] [...]

Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment

CRAIGAVON, Northern Ireland, October 7, 2010 – The need for green, economic, robust and scaleable processes
for the synthesis of chiral APIs and intermediates prompted Almac (CPHI Booth
4F32) to build and fully integrate a biocatalysis group into its service
portfolio. Last year Almac launched carbonyl reductase, transaminase,
hydrolase, nitrilase, and nitrile hydratase enzyme screening kits and is
continuing [...]

IDEV Technologies Completes US$46 Million Preferred Stock Financing With Piper Jaffray and Additional Strategic Investor

Proceeds to Fund Clinical Trials, New Product Development, Continued Revenue Growth

WEBSTER, Texas, October 7, 2010 – IDEV Technologies, Incorporated (IDEV), an emerging leader in the
development and commercialization of minimally invasive medical technologies,
today announced that it has completed a US$46 million Series D round of
financing, with Piper Jaffray & Co.'s Merchant Banking Fund (PJC Capital [...]

Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets

Updated Study Results to be Presented on ALK inhibitor (PF-02341066) and Pan-HER Inhibitor (PF-00299804) in Non-Small Cell Lung Cancer

NEW YORK, October 7, 2010 – Pfizer Oncology will present new data across its portfolio representing
novel approaches to researching treatments for patients with rare and
difficult-to-treat cancers. These results will be presented at the 35th
European Society for [...]

2nd Call for DigestScience European Projects for a Total of 500,000 Euros

The Manipulation of Intestinal Flora: A New Challenge in the Treatment of Digestive Tract Diseases…

LOOS, France, October 7, 2010 – The DigestScience Foundation is launching a European call for tenders to
support cutting-edge research into digestive tract diseases: "Manipulation of
intestinal flora in health and disease : areas of interest include
genetically selected/modified organisms, virus, phages, parasites, [...]

Oral Tasocitinib Demonstrates Statistically Significant Response by 12 Weeks in Phase 2 Study of People With Moderate to Severe Plaque Psoriasis

Results Presented at the Annual Meeting of the European Academy of Dermatology and Venereology in Gothenburg, Sweden

NEW YORK, October 7, 2010 – Pfizer Inc. (NYSE: PFE) today announced that data from a Phase 2 efficacy
and safety study of tasocitinib (proposed INN name for CP-690,550), the
company's investigational oral JAK inhibitor, met its primary endpoint of [...]

Philips Introduces New Patient Monitoring System Enabling Easy Access to Patient Information and Facilitating Effective Care Delivery

ANDOVER, Massachusetts, October 7, 2010 – Royal Philips Electronics (NYSE: PHG, AEX: PHI) today introduced the
IntelliVue MX800 patient monitoring system, a new dimension in patient care
that provides immediate access to comprehensive patient information directly
at the monitor. In addition to displaying and recording traditional data such
as patient vital signs, the IntelliVue MX800 offers direct access [...]

Majestic MRSS Adds Focus Vision in Singapore

MUMBAI, India, October 7, 2010 – MMRSS which has been expanding its geographic footprint over the past 5
years announced the opening of qualitative research facility in Singapore.

The state of the art one way mirror facility is Focus Vision enabled and
is large enough to host Super Focus Groups (Super FG's). The [...]